Jun 2026 (Q2 FY26) — Aug 10, 2026
P3 Health Partners Q2 FY26 — Strong Performance and Raised Outlook Driven by Operational Execution and Payer Settlements
Read the full callP3 Health Partners (PIII) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
P3 Health Partners earnings: last reported Mon, 10 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 386 | +8.6% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 10.7 | +20.3 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 7.4 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$4.14 −5.26% · −$0.23
Performance −54.5% 1Y
1Y: $9.09 on 14 Oct 2025 → $4.14. High $16.47 (28 May 2026), low $1.52 (2 Feb 2026).
- Previous close
- $4.37
- 52-week range
- $1.52 – $16.47
- One year
- −53.06%
Overview
- Symbol
- PIII
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
P3 Health Partners earnings calls (PIII)
Financials
What the filings say
Net profit, year on year: +137% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 362 | 371 | 373 | 356 | 345 | 385 | 386 | 386 |
| Operating profit | -107 | -139 | -38 | -34 | -44 | -154 | 8 | 41 |
| Operating margin | −29.6% | −37.4% | −10.2% | −9.6% | −12.8% | −40.0% | 2.1% | 10.7% |
| Other income | 1 | 14 | -5 | -8 | -25 | -13 | -16 | -24 |
| Profit before tax | -106 | -124 | -43 | -42 | -69 | -167 | -8 | 17 |
| Tax rate | 3.4% | −4.0% | −2.5% | −4.8% | −0.0% | 0.6% | 138.2% | 7.5% |
| Net profit | -47 | -59 | -20 | -20 | -32 | -76 | 1 | 7 |
| EPS ($ per share) | -14.36 | — | -6.28 | -6.23 | -9.67 | — | 0.37 | 0.63 |
| Line item | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Reserves | — | -130 | — | -310 | -367 | -503 | -651 |
| Total liabilities | — | 146 | — | 354 | 427 | 634 | 797 |
| Fixed assets | — | 6 | — | 9 | 9 | 6 | 3 |
| Total assets | — | 106 | — | 877 | 861 | 783 | 657 |
| Line item | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -28 | -25 | -51 | -126 | -76 | -110 | -91 |
| Cash from investing | -4 | -3 | -8 | -8 | -2 | 15 | 0 |
| Cash from financing | 64 | 35 | 25 | 11 | 100 | 99 | 73 |
| Net cash flow | 31 | 7 | -35 | -122 | 22 | 3 | -18 |
| Capital expenditure | -1 | -3 | -3 | -2 | -2 | 0 | — |
| Free cash flow | -30 | -28 | -54 | -128 | -78 | -110 | — |
Insider filings
7 filings between Jun 10, 2026 and Aug 13, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$823.9K
3 sales by 1 insider
Also filed: 2 conversions, 2 other filings.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Hudson Vegas Investment SPV, LLC | — | $823.9K | Aug 10, 2026 |
Latest filings (23)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Aug 13, 2026 | Hudson Vegas Investment SPV, LLC 10% owner | Other | 100,000 | — |
| Aug 13, 2026 | Hudson Vegas Investment SPV, LLC 10% owner | Conversion | 100,000 | — |
| Aug 10, 2026 | Hudson Vegas Investment SPV, LLC 10% owner | Sale | 19,074 | $306.1K |
| Aug 10, 2026 | Hudson Vegas Investment SPV, LLC 10% owner | Sale | 29,885 | $503.9K |
| Aug 10, 2026 | Hudson Vegas Investment SPV, LLC 10% owner | Sale | 1,041 | $13.9K |
| Jun 10, 2026 | Hudson Vegas Investment SPV, LLC 10% owner | Conversion | 50,000 | — |
| Jun 10, 2026 | Hudson Vegas Investment SPV, LLC 10% owner | Other | 50,000 | — |
| Aug 6, 2025 | Kazarian Gregory N. Director | Award | 2,000 | $0 |
| Aug 6, 2025 | WASSON GREGORY D Director | Award | 2,000 | $0 |
| Aug 6, 2025 | TOLAN MARY A Director | Award | 2,000 | $0 |
| Aug 6, 2025 | Thierer Mark Director | Award | 4,000 | $0 |
| Aug 6, 2025 | Park Jeffrey G Director | Award | 2,000 | $0 |
| Aug 6, 2025 | Price Thomas Edmunds Director | Award | 2,000 | $0 |
| Aug 6, 2025 | Leisure Lawrence B. Director | Award | 2,000 | $0 |
| Sep 13, 2024 | Chicago Pacific Founders UGP III, LLC 10% owner | Purchase | 80,000 | $40.0K |
| Sep 12, 2024 | Chicago Pacific Founders UGP III, LLC 10% owner | Purchase | 80,000 | $41.6K |
| Sep 11, 2024 | Chicago Pacific Founders UGP III, LLC 10% owner | Purchase | 80,000 | $44.7K |
| Sep 10, 2024 | Chicago Pacific Founders UGP III, LLC 10% owner | Purchase | 80,000 | $41.2K |
| Sep 9, 2024 | Chicago Pacific Founders UGP III, LLC 10% owner | Purchase | 80,000 | $42.7K |
| Sep 6, 2024 | Chicago Pacific Founders UGP III, LLC 10% owner | Purchase | 80,000 | $39.2K |
| Sep 5, 2024 | Chicago Pacific Founders UGP III, LLC 10% owner | Purchase | 80,000 | $39.3K |
| Sep 4, 2024 | Chicago Pacific Founders UGP III, LLC 10% owner | Purchase | 80,000 | $39.1K |
| Sep 14, 2023 | Chicago Pacific Founders UGP III, LLC 10% owner | Purchase | 90,000 | $227.1K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for P3 Health Partners Inc.
Free account. Everything above stays public.
Write why you follow P3 Health Partners Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading